关注
Paolo Monardo
Paolo Monardo
MD
在 aopapardo.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients
V Savica, D Santoro, G Mazzaglia, F Ciolino, P Monardo, M Calvani, ...
Journal of Renal Nutrition 15 (2), 225-230, 2005
1262005
Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients
V Savica, LA Calo, P Monardo, PA Davis, A Granata, D Santoro, R Savica, ...
Journal of the American Society of Nephrology 20 (3), 639-644, 2009
852009
Phosphate binders and management of hyperphosphataemia in end-stage renal disease
V Savica, LA Calo, P Monardo, D Santoro, G Bellinghieri
Nephrology Dialysis Transplantation 21 (8), 2065-2068, 2006
692006
Salivary phosphate secretion in chronic kidney disease
V Savica, L Calo, D Santoro, P Monardo, A Granata, G Bellinghieri
Journal of renal nutrition 18 (1), 87-90, 2008
642008
Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin
S Campo, A Lacquaniti, D Trombetta, A Smeriglio, P Monardo
Journal of Clinical Medicine 11 (13), 3759, 2022
562022
Carnitine system in uremic patients: molecular and clinical aspects
V Savica, M Calvani, P Benatti, D Santoro, P Monardo, G Peluso, ...
Seminars in nephrology 24 (5), 464-468, 2004
542004
Nutritional status in hemodialysis patients: options for on-line convective treatment
V Savica, F Ciolino, P Monardo, A Mallamace, R Savica, D Santoro, ...
Journal of renal nutrition 16 (3), 237-240, 2006
472006
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: multicenter prospective study in Italy
L De Nicola, M Provenzano, P Chiodini, G D'Arrigo, G Tripepi, ...
Nutrition, Metabolism and Cardiovascular Diseases 25 (8), 756-762, 2015
342015
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
V Savica, LA Calo, A Granata, R Caldarera, A Cavaleri, D Santoro, ...
Clinical nephrology 68 (4), 216-221, 2007
342007
An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and facts.
V Savica, G Bellinghieri, P Monardo, U Muraca, D Santoro
Journal of Nephrology 26 (3), 456-464, 2012
332012
Urine therapy through the centuries.
V Savica, LA Calò, D Santoro, P Monardo, A Mallamace, G Bellinghieri
Journal of nephrology 24, S123-5, 2011
332011
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
V Savica, D Santoro, P Monardo, A Mallamace, G Bellinghieri
Therapeutics and Clinical Risk Management 4 (4), 821-826, 2008
292008
Salivary glands: a new player in phosphorus metabolism
V Savica, LA Calò, D Santoro, P Monardo, G Santoro, U Muraca, ...
Journal of Renal Nutrition 21 (1), 39-42, 2011
262011
Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia
V Savica, LA Calò, P Monardo, D Santoro, A Mallamace, U Muraca, ...
Journal of Renal Nutrition 19 (1), 69-72, 2009
232009
High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk
V Savica, LA Calò, P Monardo, R Caldarera, A Cavaleri, D Santoro, ...
Nutrition, Metabolism and Cardiovascular Diseases 18 (8), e39-e40, 2008
232008
Clinical policies on the management of chronic kidney disease patients in Italy
F Locatelli, C Zoccali, SIR SIN Study Investigators
Nephrology Dialysis Transplantation 23 (2), 621-626, 2008
222008
Acute kidney injury and sepsis after cardiac surgery: the roles of tissue inhibitor metalloproteinase-2, insulin-like growth factor binding protein-7, and mid-regional pro …
A Lacquaniti, F Ceresa, S Campo, G Barbera, D Caruso, E Palazzo, ...
Journal of Clinical Medicine 12 (16), 5193, 2023
212023
Updates on hemodialysis techniques with a common denominator: The personalization of the dialytic therapy
P Monardo, A Lacquaniti, S Campo, M Bucca, T Casuscelli di Tocco, ...
Seminars in dialysis 34 (3), 183-195, 2021
212021
Fabry disease and kidney involvement: starting from childhood to understand the future
R Chimenz, V Chirico, C Cuppari, G Ceravolo, D Concolino, P Monardo, ...
Pediatric Nephrology 37, 95-103, 2022
172022
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study
R Minutolo, M Provenzano, P Chiodini, S Borrelli, C Garofalo, ...
Clinical Kidney Journal 15 (6), 1120-1128, 2022
142022
系统目前无法执行此操作,请稍后再试。
文章 1–20